CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Assertio Holdings inc   (NASDAQ: ASRT)


Assertio Holdings Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Assertio Holdings Inc's ROI in the first quarter of 2026?
Assertio Holdings Inc recorded a cumulative net loss of $-36 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -25.68%.

Within the Healthcare sector 336 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from 2926 to 2993.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Investment Change TTM -20.68 % -18.97 % -17.7 % -21.63 % -28.05 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 120 142 153 141 158
Return On Investment (TTM) -25.68 % -20.46 % -18.6 % -26.45 % -17.47 %
ASRT's Overall Ranking # 2993 # 2926 # 3077 # 3089 # 3036
Seq. Investment Change TTM -6.38 % -4.53 % -5.03 % -6.57 % -4.36 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -36 -30 -29 -43 -31

ASRT Company Profile >> Back to ASRT Roi Comparisons >> See Annual ASRT Return On Investment



Return On Investment ASRT's Ranking
Within: No.
Industry # 120
Sector # 337
Overall # 2993

Return On Investment Statistics
High Average Low
45.86 %
-15.47 %
-165.23 %
(Dec 31 2022)   (Jun 30 2024)



  News about Assertio Holdings inc Return on Investment ROI

“Assertio Holdings: Navigating Leadership Changes and Clinical Innovations in Oncology After Revenue Challenges”,

December 12, 2024

Assertio Holdings: Strategic Leadership Changes and Clinical Innovations in Oncology Amid ChallengesAssertio Holdings, Inc. a notable player in the pharmaceutical landscape, is gearing up for a pivotal shift under new leadership while navigating clinical innovations in oncology. The recent appointments of Paul Schwichtenberg as Chief Technology Officer (CTO) and Mary Pietryga as Chief Commercial Officer (CCO) signal Assertio s strategic focus on market expansion and revenue generation. These moves come at a crucial time when the company is also analyzing the economic and clinical implications of its innovative oncology treatment, Rolvedon (eflapegrastim-xnst).Leadership Changes: A Catalyst for GrowthOn December 13, 2024, Assertio made





Financial Statements
Assertio Holdings Inc's I. Quarter Investments $ 120 Millions ASRT's Balance sheet
Assertio Holdings Inc's I. Quarter Income $ -19 Millions Quarterly ASRT's Income Statement
ASRT's Income by Division See ASRT's Income by Division


ASRT Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 139 170 193 319 192
Y / Y Investment Growth -17.99 % -11.88 % -39.43 % 66.34 % 12.28 %
Net Income in Millions -30 -22 -332 110 -1
Y / Y Net Income Growth - - - - -
Annual Return On Investment -21.78 % -12.69 % -172.01 % 34.41 % -0.67 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ASRT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ASRT's Competitors
Subscribers only: Roi for Assertio Holdings Inc's Suppliers
Subscribers only: Return On Investment for ASRT's Customers

Other Ratios
ASRT's Roa ASRT's Inventory Turnover Ratio ASRT's Growth Rates ASRT's Dividend Statistics
ASRT's Profitability Ratios ASRT's Asset Turnover Ratio ASRT's Dividend Growth
ASRT's Roe ASRT's Valuation Ratios ASRT's Financial Strength Ratios ASRT's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:38:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.